COVID-19: US Withdraws Emergency Use of Hydroxychloroquine

Emergency use of the antimalarial drug hydroxychloroquine as coronavirus therapy has been withdrawn by the US Food and Drug Administration (FDA).

The FDA said that recent findings from clinical studies indicated that it was no longer fair to assume that the medication would have an antiviral effect.

US President Donald Trump later justified the usage of hydroxychloroquine as a cure for Covid-19, BBC reported.

In March, the FDA approved the emergency use of the medication in some serious cases.

But on Monday, the agency said clinical studies had suggested that hydroxychloroquine was ineffective in treating the deadly virus and failed to prevent infection among those exposed to it.